Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Cyclin E1 Antikörper

CCNE1 Reaktivität: Human WB, IF, FACS, IHC (p) Wirt: Maus Monoclonal HE12 unconjugated
Produktnummer ABIN567783
  • Target Alle Cyclin E1 (CCNE1) Antikörper anzeigen
    Cyclin E1 (CCNE1)
    Reaktivität
    • 148
    • 38
    • 34
    • 3
    • 2
    • 2
    • 2
    Human
    Wirt
    • 124
    • 23
    • 1
    Maus
    Klonalität
    • 114
    • 34
    Monoklonal
    Konjugat
    • 83
    • 8
    • 6
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    Dieser Cyclin E1 Antikörper ist unkonjugiert
    Applikation
    • 104
    • 48
    • 47
    • 42
    • 34
    • 28
    • 21
    • 13
    • 13
    • 10
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
    Spezifität
    This antibody reacts with Cyclin E (50 kDa) on Western blotting. This monoclonal antibody may nonspecifically react with macrophages, endothelial cells and some stromal cells in Immunohistochemistry.
    Aufreinigung
    Protein-A Agarose Chromatography of hybridoma supernatant.
    Immunogen
    Human recombinant full length His-Cyclin E.
    Klon
    HE12
    Isotyp
    IgG1
    Top Product
    Discover our top product CCNE1 Primärantikörper
  • Applikationshinweise
    Optimal working dilution should be determined by the investigator.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Konzentration
    1.0 mg/mL
    Buffer
    PBS, pH 7.2 containing 50 % Glycerol without preservatives.
    Konservierungsmittel
    Without preservative
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    -20 °C
    Informationen zur Lagerung
    Store the antibody (in aliquots) at -20 °C.
  • Target
    Cyclin E1 (CCNE1)
    Andere Bezeichnung
    Cyclin E1 (CCNE1 Produkte)
    Synonyme
    CCNE1 antikoerper, ccne antikoerper, cyclinE antikoerper, CCNE antikoerper, AW538188 antikoerper, CycE1 antikoerper, CYCLE antikoerper, Ccne antikoerper, cyce2 antikoerper, cycE3 antikoerper, cyce antikoerper, fa18e07 antikoerper, wu:fa18e07 antikoerper, cyclin E1 antikoerper, cyclin E1 L homeolog antikoerper, cyclin E1 S homeolog antikoerper, CCNE1 antikoerper, ccne1 antikoerper, Ccne1 antikoerper, ccne1.L antikoerper, ccne1.S antikoerper
    Hintergrund
    Cyclin E, a positive regulator of the cell cycle, controls the transition of cells from G1 to S phase. Cyclin E forms a complex with Cdk2, the active kinase follows cyclin D/Cdk4 in progressively phosphorylating pRb, releasing it from members of the E2F family. E2F transcrIPPtion factors in turn activate a set of target genes that are essential for entry into S phase. Deregulation of the G1-S checkpoint contributes to uncontrolled cell division, a hallmark of cancer. Cyclin E overexpression and deregulation have been shown in several cancers including breast, colorectal, gastric and lungSynonyms: CCNE, CCNE1, Cyclin-E1
    Gen-ID
    898
    NCBI Accession
    NP_001229
    UniProt
    P24864
    Pathways
    Zellzyklus, Intracellular Steroid Hormone Receptor Signaling Pathway, Nuclear Hormone Receptor Binding, Mitotic G1-G1/S Phases
Sie sind hier:
Kundenservice